Lamivudine Tablet shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Oct 19, 2026 · last update Oct 19, 2026
Manufacturers: ViiV Healthcare Company
Stated reasons (per FDA): Not stated (FDA did not give a reason)
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Epivir, Tablet, 150 mg (NDC 49702-203-18) | ViiV Healthcare Company | To Be Discontinued | — | The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug | Posted Oct 19, 2026 Updated Oct 19, 2026 Discontinued Oct 19, 2026 |
| Epivir, Tablet, 300 mg (NDC 49702-204-13) | ViiV Healthcare Company | To Be Discontinued | — | The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug | Posted Oct 19, 2026 Updated Oct 19, 2026 Discontinued Oct 19, 2026 |